Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes

Regulatory Peptides

Volumn 166, Issue 1-3, 2011, Pages 48-54

  Vaghasiya, Jitendra ^a   Sheth, Navin ^b   Bhalodia, Yagnik ^c   Manek, Ravi ^c  

^a Jodhpur National University   (India)

^b SAURASHTRA UNIVERSITY   (India)

^c SNDT WOMEN S UNIVERSITY   (India)

Author keywords

Inflammation; Ischemia reperfusion; Oxidative stress; Renal damage; Sitagliptin

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CATALASE; CREATININE; DNA; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID; MYELOPEROXIDASE; NICOTINAMIDE; NITRIC OXIDE; SITAGLIPTIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA DERIVATIVE; UREA NITROGEN; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DNA FRAGMENTATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; INFLAMMATION; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; REPERFUSION; TISSUE LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; APOPTOSIS; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DNA FRAGMENTATION; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PEROXIDASE; PYRAZINES; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TRIAZOLES; XANTHINE OXIDASE;

RATTUS;

EID: 78650175802     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.08.007     Document Type: Article

References (42)

1. Goor Y., Peer G., Iaina A., Blum M., Wolman Y., Chernihovsky T., Silverberg D., Cabili S. Nitric oxide in ischemic acute renal failure of streptozotocin diabetic rats. Diabetologia 1996, 39:1036-1040.
2. Wald H., Markowitz H., Zevin S., Popovtzer M.M. Opposite effects of diabetes on nephrotoxic and ischemic acute tubular necrosis. Proc Soc Exp Biol Med 1990, 195:51-56.
3. Basireddy M., Isbell T.S., Teng X., Patel R.P., Agarwal A. Effects of sodium nitrite on ischemia-reperfusion injury in the rat kidney. Am J Physiol Renal Physiol 2006, 290:F779-F786.
4. Noiri E., Nakao A., Uchida K., Tsukahara H., Ohno M., Fujita T., et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001, 281:F948-F957.
5. Ysebaert D.K., De Greef K.E., De Beuf A., Van Rompay A.R., Vercauteren S., Persy V.P., et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 2004, 66:491-496.
6. Altunoluk B., Soylemez H., Oguz F., Turkmen E., Fadillioglu E. An angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci 2006, 36:326-332.
7. Melin J., Hellberg O., Akyurek L.M., Kallskog O., Larsson E., Fellstrom B.C. Ischemia causes rapidly progssive nephropathy in the diabetic rat. Kidney Int 1997, 52:985-991.
8. Deacon C.F. Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes. Expert Opin Investig Drugs 2007, 16:533-545.
9. Drucker D., Easley C., Kirkpatrick P. Sitagliptin. Nat Rev Drug Discov 2007, 6:109-110.
10. Herman G.A., Stein P.P., Thornberry N.A., Wagner J.A. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin. Clin Pharmacol Ther 2007, 81:761-767.
11. Baggio L.L., Drucker D.J. Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review. Treat Endocrinol 2002, 1:117-125.
12. Deacon C.F., Holst J.J. Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective. Biochem Biophys Res Commun 2002, 294:1-4.
13. Holst J.J. Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential. Curr Med Chem 1999, 6:1005-1017.
14. Wei Y., Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 1995, 358:219-224.
15. Bose A.K., Mocanu M.M., Carr R.D., Brand C.L., Yellon D.M. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 2005, 54:146-151.
16. Bose A.K., Mocanu M.M., Carr R.D., Yellon D.M. Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model. Cardiovasc Drugs Ther 2005, 19:9-11.
17. Bose A.K., Mocanu M.M., Carr R.D., Yellon D.M. Myocardial ischaemia reperõfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway. Cardiovasc Drugs Ther 2007, 21:253-256.
18. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998, 47:224-229.
19. Slater T.F., Sawyer B.C. The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in liver fractions in vitro. Biochem J 1971, 123:805-814.
20. Moran M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979, 582:67.
21. Misra H.P., Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay of SOD. J Biol Chem 1972, 247:3170.
22. Aebi H. Oxidoreductases acting on groups other than CHOH: catalase. Methods in enzymology 1984, 121-125. Academic Press, London. S.P. Colowick, N.O. Kaplan, L. Packer (Eds.).
23. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte peroxidase. J Lab Clin Med 1967, 2:158.
24. Prajda N., Weber G. Malign transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett 1975, 59:245-249.
25. Guevara I., Iwanejko J., Dembinska-Kiec A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998, 274:177-188.
26. Wei H., Frenkel K. Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters. Carcinogenesis 1993, 14:1195-1201.
27. Matsuyama M., Yoshimura R., Hase T., Kawahito Y., Sano H., Nakatani T. Study of cyclooxygenase-2 in renal ischemia-reperfusion injury. Transplant Proc 2005, 37:370-372.
28. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Oxygen radicals in biological systems 1990, 186:464-478. Academic Press, California. L. Packer, A.N. Glazer (Eds.).
29. Sakr M., Zetti G., McClain C., Gavaler J., Nalesnik M., Todo S., et al. The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation 1992, 53:987-991.
30. Yagmurca M., Erdogan H., Iraz M., Songur A., Ucar M., Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004, 348:27-34.
31. Arnhold J., Osipov A.N., Spalteholz H., Panasenko O.M., Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med 2001, 31:1111-1119.
32. Yagmurca M., Erdogan H., Iraz M., Songur A., Ucar M., Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004, 348:27-34.
33. Sudnikovich E.J., Maksimchik Y.Z., Zabrodskaya S.V., Kubyshin V.L., Lapshina E.A., Bryszewska M., et al. Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rats. Eur J Pharmacol 2007, 569:180-187.
34. Madar Z., Kalet-Litman S., Stark A.H. Inducible nitric oxide synthase activity and expression in liver and hepatocytes of diabetic rats. Pharmacology 2004, 73:106-112.
35. Kurcer Z., Parlakpinar H., Vardi N., Tasdemir S., Iraz M., Fadillioglu E., et al. Protective effects of chronic melatonin treatment against renal ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes 2007, 115:365-371.
36. Sutherland G.R., Peeling J., Sutherland E., Tyson R., Dai F., Kozlowski P., et al. Forebrain ischemia in diabetic and nondiabetic BB rats studied with 31P magnetic resonance spectroscopy. Diabetes 1992, 41:1328-1334.
37. Moursi M., Rising C.L., Zelenock G.B., D'Alecy L.G. Dextrose administration exacerbates acute renal ischemic damage in anesthetized dogs. Arch Surg 1997, 122:790-794.
38. Chen H., Xing B., Liu X., Zhan B., Zhou J., Zhu H., et al. Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol 2008, 581:306-314.
39. Hyo J.K., Ki W.L., Mi-Sung K., Hyong J.L. Piceatannol attenuates hydrogen peroxide- and peroxynitrite-induced apoptosis of PC12 cells by blocking down-regulation of Bcl-XL and activation of JNK. J Nutr Biochem 2007, 7:459-466.
40. Timmers L., Henriques J.P., de Kleijn D.P., Devries J.H., Kemperman H., Steendijk P., et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. JACC 2009, 53:501-510.
41. Zhai W., Cardell M., De Meester I., Augustyns K., Hillinger S., Inci I., Arni S., et al. Ischemia/reperfusion injury: the role of CD26/dipeptidyl-peptidase-IV-inhibition in lung transplantation. Transplant. Proc. 2006, 38:3369-3371.
42. Wolfgang J., Ingrid D.M., Veerle M., Ilhan I., Koen A., Simon S., Walter W., Stephan K. Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide. Peptides 2010, 31:585-591.